Philip Morris
Fields
- Author
- Farley, P.J.
- Area
- WAKEHAM,HELMUT/KAROL SHARPE'S OFFICE
- Type
- LETT, LETTER
- Named Organization
- Coca Cola
- Natl Distillers & Chemical
- Pepsi Cola
- Standard Oil
- Stanford Univ
- Boston Globe
- Natl Distillers & Chemical
- Request
- Stmn/R1-004
- Stmn/R1-150
- Recipient
- Miller, A.
- Master ID
- 1000229536/9811
Related Documents:- 1000229545-9550 Brief Synopsis
- 1000229551-9552 Introduction
- 1000229553-9555 Brief History of Cetus Financing
- 1000229556-9557
- 1000229558-9560 Special Note to Investors
- 1000229561-9563 Special Note Regarding Founder's Stock
- 1000229567-9569 Board of Directors
- 1000229575-9580 Achievements of Cetus People
- 1000229581-9599 Present Cetus Activities
- 1000229600-9616 Research Plan
- 1000229617-9619 Patents
- 1000229621-9656 Debenture Purchase Agreement
- 1000229657-9661 the Cetus Story
- 1000229663-9667 Cloning Business: It's Growing Fast It's Growing Fast
- 1000229668 World Roundup
- 1000229669-9670 Latin Drive: Brazil Spends Millions to Put Alcohol in Cars and Save Oil
- 1000229671 Can US Reduce Imports with Gasoline? Some Say Yes, But Officials Are Dubious
- 1000229672-9673 Bacterial Insulin Production Hears Reality
- 1000229674 Business World
- 1000229675-9677 Who Should Play God?
- 1000229678 Schering Plough New York Analysts' Meeting December 7, 1977
- 1000229679 Indiana Standard Labels Purchase Offer Part of Move to Wider Technology Base
- 1000229680 Big Deal for Berkley Bugs
- 1000229681 Oil-Less World May Run on Bugs
- 1000229682-9685 Tinkering with Life
- 1000229686-9687 Set for Biology's New Revolution
- 1000229688 Little Black Box of Cetus
- 1000229689-9695 Industry Is Finding More Jobs for Microbes
- 1000229696-9701 Dup of Id 1000229657-9661
- 1000229702-9710 Recombinant Molecular Research at Cetus Corporation
- 1000229711-9715 New Cetus Antibiotic
- 1000229716-9720 Letter to the Shareholders
- 1000229721-9726 Letter to Shareholders
- 1000229727-9728 Letters to the Shareholders
- 1000229729-9730
- 1000229731-9734 Letter to the Shareholders
- 1000229735-9736 Letter to Shareholders
- 1000229737-9749 the Manipulation of Genes
- 1000229750-9770 Microbial Genetics and the Future of the Pharmaceutical Industry
- 1000229771-9774 Recombinant Dna: Fact and Fiction
- 1000229775-9778 Testomony of Ronald E Cape, Phd President, Cetus Corporation, Berkeley, California Before the House Subcommittee on Science, Research and Technology
- 1000229779-9797 Biosystems Poised for Growth
- 1000229798-9805 Testimony of Ronald E. Cape, Ph.D President, Cetus Corporation, Berkley, California Before the Senate Subcommittee on Science, Technology and Space
- 1000229806-9807 Statement of Ronald E. Cape, Ph.D President, Cetus Corporation, Berkeley, California Before A Special Joint Congressional Hearing in Conjunction with Oversight Hearings on Science and Technology Policy the Senate Subcommittee on Science, Technology and Space of the Commerce, Science and Transportation Committee Presiding, Senator Adlai Stevenson, III Washington, Dc
- 1000229808-9811 Statement of Ronald E. Cape, Ph.D. President, Cetus Corporation, Berkeley, California at the Annual Meeting of the American Association for the Advancement of Science Session on Recombinant Dna Public Health and Biomedical Research Policy Washington, D.C.
- Author (Organization)
- Cetus
- Litigation
- Stmn/Produced
- Site
- R37
- Characteristic
- CONF, CONFIDENTIAL
- Date Loaded
- 05 Jun 1998
- UCSF Legacy ID
- cfi84e00
Document Images
a
x
,
t~.
July 7, 1978
Mr. Ar jay Asiller
-.i
Dean
=
Graduate School ot..Buaiaess :.,
Stanford vaiaersity
~
Stanford, -94305
, l+:. n;
Dear Arjays
A
. . i.i..,~
i
ti,~e er
!
e
£F
t
.~:
~
>
r.
,.
xt

r
n
t
:.
M
iTJ
7
5
.
M
B
.
,
.M
1
W
,
,
r.
.a. . i.. t
..- .~'
~ , r..
~ ~. .,.. i ~-
, ..
,
~.- . ,._ . . ~ ~
. ~_ . . ..... . . _.
.
! 7 ~ . .. . . ~ . .
1, .b-=- ilk._
,
,
f
O
s
T ytu
0
n
Y
ff
1
}ir
t
m
t

t
tr~
,Y.
7
Mr. Arjay Miller
July 7, 1978
Page 2
:r'~_ ~ ... . _. .... ,......
0
0
+-.. .. s a
t
.1
K
s
4
A
,.
i
S
S
CI?
J;F
.._. ~P7..P.1
IN
t
t'

i
Ail
6
1
4
~
Y.
r . . . . . ~, . ~,. .."~~' .. . . . .~~' ~
'.! . , . . _. . . ~ ~ ~ f . . , ~ ...
O'!
N
1
9
a
a
r
A
rR
S
1
v~t
1
A
y
t
r
- ~

.
;~.
^ ~ , i t s .r txt. ..6. >GY ss ,, ~
F ~ , ~ .. .~. .
,. .~~ .. ~ .,. _ `
s
~.. Mr. Arjay Miller July 7, 1978
Page 3
-~.
ctorodis over .v . ., _ ,. : . .
p g , will produce peptides. Biologically active
human
peptides, ed only in the past few years, represent one of
~ YY
V
. , p
i
' Cetus is in a unique position to take advantagetiof-'
m ~N
fly ~~fj~f~='~,Y`~~Y
Within the past year, twoof our corporate, c;iexits have~~ach purchased'~
i
r
h
l
20%
i
i
~o
h c
he
es
.
approx
mate
of the equ
y
ty
n Cetus. ~n
t
ases, t
pu
c
as
r . '^A7 3 f
~ were entirely arms length'and independento£~any cla.en t -relationshiptJ + ent-relationship
Y: : , . 1 ' ` V r"~~. y`*T
with Cetus.. The Standard Oil Cot tifIndiaMay~investment involved pur
`
chases from Cetus and also from siiareholders; National Distillers and ?
~`,
Chemical Corporation purchased s~ock
froaa shareholders. Both companies
w I
have Board representation and.case the relationship is exceed-:
3~n each'
ingly cordial. In each case_`fhe intent was to monitor the development
.
t
% J1i`S
,
>-
, ;rs of what we all perceive tabe an~, explosive growth opportunity over
w .,r the next twent
ears Y
y y
' 4
a~~~QJV`. ~ ~-
r QV s,K ~4~ .~C~
~ As part of the Standard Oil._purchase agreement, that company obtained
the right of first opportunit'p,~ at a pre-agreed upon price to purchase
, the next $9,00O,OOa;of stock sold by the company.. Cetus in return
''
:~esY +:;~
~ received a"Put."4~We can put $5,000,000 to them (which funds are ear
'~
n
, y'marked for propri tary Cetus research) and Standard Oil has thirty days
in which to respond;"yes'k or "no." Two months ago our Board decided {r_~
unanimously (Standard 0i1 abstaining) that it was in the best interest
f' Ct tk'~thirdtthld Stdd Oil
oeuso see, < major corporae parner souanar
'- ~t""3ra
~ ° This
Standard did one month a
ever refuse a"Put: "
o
th
for a
!4
.c,
,
g
,
us
ir: Q O. . a K f w 3~
period of 180-°daystiwe are free to raise this money elsewhere.: In point .
"
o fact, Standa=d~was quite willing to provide the additional funds and,
f
indeed, is,`stil],.iailling to provide these funds._ However, the terms
°
'ir
!
:~k b'
e have, in, our opinion, two undesirable new conditions
ahat they,;
requ
not coverec~ i:n their original purchase agreement: (1) that the cash be ~: ,~ .%
f''~
~, ; provided on_ry when Cetus' working capital dipped below $1, 000, 000 rather
,,kthan up front, (2) that Standard purchase some stock from Cetus found-
ing management and in addition have the right of first opportunity, at,':
~.
market, on any subsequent sale of founding management stock. This ?.:+ Q
offer still stands. Another reason we refused is because we would
prefer to get yet another corporate partner. Therefore, we seized the
opportunity to take advantage of_their qualified "yes" answer. Our
relationship with St
ndard continues t
b
f
i
dl
d i
d
d"
~
y a
o
e a
r
en
y one an
,,
n
ee .~.
A"{
the most exciting areas in medicine today. Almost monthly, new and.
interesting peptides are being discovered in various academic centers
,~ throughout the world. The problem is that these compounds cannot be
synthesized chemically. However, here our recombinant DNA technology.
''can be useful, and within the next eighteen months, Cetus will be in a'
p
p
~ttltrY ~ i 4~h' igeY
they appear to be the master control molecules excreted by the brain ' y rO= T.~
l ~^
Peptides have been discovered that relieve pain, promote sleep,, relieve ~
s
position to rapidly produce large amounts of virtually any human peptide
~ of interest: These com
ounds are of extreme
otential value in that
examples
In short
this is an ex
losive new frontier in medicine an
our search for funds elsewhere has their blessing.
/
'4`~`anxiety, temporarily reverse schizophrenic behavior, to name some
4-

G 3~. !`_~<..., .. - . ".` . . .
~'.r.,l .
~~..
r
..
,
;~-
~
c -.
Tr.:
.. .. - ~. t ^ ~A.~~~ . . ..
9'IX~~~-yyt~~' ^a.?SLjJFt].t~ ?,~ p c7 .rr+r3+f ~ L411 ~ r r > y
~~ 4'.~
tlrz y R a ~Y~'
~ W9 L
Y `~; ~J ~'i. :'[
'7
*7 £f~ ~UGCI>r3 P.~i 4j .Cii?..: t.'r3! i4 4: ~
nQ'~}~~ 3Si10?T3-
t1 .:/
8 aL[~°6 tW
~b7~~ct~~ sI&flTa,fa~~ytlaa ~~l~t~l~~t R~
~('~
iTk
' ..,~vr~ ~'s tz = gv'4:r
' e
i
'
~iY~
{VBf~8~i7sW'~.x-:iw.~~`78 m~'°:~i`~J`f'r~.~~i;tfi~^+~tTti
k.~w
7i&:1je3~p
~~t~ I:C ~,$
3V
~~, f~'~1~
~f10S.T~V~~ tjs
iE'`J- ~
' ...'rl.~
tlO~~~
O
-q~' O~F~$,o
I Tr
f .~` ~'l~dPC)~~S` ~~r~'r~i.k'J~ ~ 3O';~lZ`el'r3~:1C'~ Lt~.h3~' Of~riT~~~at~~o1 tY13I~f(IT3 "'+
-2L't~ baJCe~rti 7C 3r~2$VfttrtTa~S~7i'~Q- ?.~.G?~L~~r.t;a.y: ~ +>a°'r t :2~~ ~J:~ f.A ~W '`
4 .
w~ 36
~
~S~ z:c tg~oi~sG3 ~2z~bfar'~~~~.os G.s ~sr.ox}
[is.: '~.5 ~rCfiL] .~~. . G . ~ ,1+,. . .. d ...:.ig'~.
S'
~Y=r..2L`'r'/ r ?L ~e~ A~ o Sti, ~ +~..~G4 G1:,eY`!"xaA ~~ ~ ^ 1A 1~ 1. -L IX ~- .~' + ~ '~'
1.1..A. .1:
1 ) . A
}~ .4 C[iI ~cjt ~~ ,O C~i ~
, ^a :~ ~0^t.~r [' LL J
Y34'O {. L?~~ {}n T 7rr G* rtn s ~. ~ , rf. X~ ' , pt3,>.
`{~ :r.'~:O GJ ~£ Z $V`1..~~at .~.i.9Le7
0ao fGjt,s~~ C
{
, ?
~, .
=L ~1 ^ ' 92~s1:~ CLC~ 'C f `4~ 'y
. .. . . _ r. ... . - ,.F'-;.. {~iL:r~:.~': _.
M
C~ a 17 VU XOO? ^Cr-..7Ouuu;lvl}uat"~e
'aC+~ YFa3` 9`f~ 2f7!'~i . t~ ~'~r -'^`.Gg+L^^
$ : :-
~~1~~ ;.` aycb y3xir;-t fL,- -,d~o:~ ~(d~xs~esY 2tsxg~ yz$fs hxsq
x
L
r~`'7~~$r
ar~ , , : ~ a y~a
y.k : urij (pain~~~Gcfs':' f kQ:bY~bi+,~~a["') 'a,rl~wo;idlrw
xtc) FJ^r'`.f7P.FA.jl o:; i. '1'2x~' 9Jb7oqYq~AQ3 b Y2Als_`119S2rQ~jt 21('.f e"]
/
;5 10 s~Y:~
n.
~~ ~flLrJC iLr ?,Tr{a
t , Srm ab,-w
3 L~r ~sfij: Ebs.rotq;W
rzi tLtw ~3 ~Aa zsw~ sb~YS~2 ~°X , ~':
. 4: 4 o11TS9~y t~t ,t ~~
x y~,O~ JH .&x at~~,. 37?N t t1: .C~T07i .~ .Q~,'. L'Tl.$+''~5.:~ f~G',..yrySE ~~ 9 S?a~ C :
~'
-J` 2~...r`t .rS=?G~.~
wY
z 9d3hY~f:ao~~~~,~~~~~J
r~ 9d3hY OL""~~zK) bfitY r:;'oL~cs f~qgtls. Ssjiq~zo prtl:{Yow -! aad9~ rtsr3~r
.bftd1U~ 2L~p~`~' ^:C3'SI ]~Jf12 9rTD~2 98$~+JYlSq f~Yl"o:aIB~2
-js y:tirurd YOqqo ~a
ii3 _30 -1 cipiY e1f:j Dvsrft, no.ilicbA rtC
;.=. ;..; L ir'T n4Rt pr,lsJliilo: 30 s1sa lttsriD9ctciii?. ynS::11Q y~5nxii~[q
,: .
Fi 5tuow 9w C,at,zoscf 2i A5clJi9Y 9w noa.aez xsf3vtsFti' `abns~~ ,I~~~,=a~~~ci , 0 y C 9f~J £ 3S
[92 9 v' , 9 f 03-roriT 79azt-isq 91sZod'xoo 2,31:M orrb
Yu0 ."C4J.2t.r.
10 9ie
rtw i°, ~ fJ- Qbf7I f"i '~2Ca g,n,0 5°C{ .].I fJ7~f, fiAJ;5 d-t1tJ'' qlw t!ir"3 r~~ ~^'~ s W
r'.n 1.
~ '$
t
f
c
n
i
h

t,
.
milling industry. Specifically, a biologically-produaed enzyme made
M
.
t
. ~.. ~ .
Mr. Arjay Miller
July 7, 1978 "'
Page 4
I'm writing to you because of your close personal relationship with many
chief executive officers. Your judgment can be of great value to us.
X You understand Cetus and you have watched us grow over the past seven
years. What we need now is an introduction to the type of individual
":. who can grasp the importance of our fundamental message and who is in a position to be able to
act. That message is very simple. Biology has
ts"h "k ,
made incredible strides in the past ten years. It has reached the point
w of practical, comnercial application to industries that heretofore have
never utilized biology as a tool. There are going to be and, indeed,
have already been major dislocations in basic industries because of
biological innovation. A most striking example would be the loss by the
°: sugar indus ~
}''F try of 30% of the industrial sweetener market to the corn wet
0
0
41t
possible the conversion of corn starch to high fructose corn syrup.
This' syrup has now becosae a major sweetener for,use by the~-likes of~
Coca-Cola, Pepsi Cola, the candy.and baking industries,~etc.;`Cetus +own
process for producing propylene and/or ethylene'oxide~and glycol,"if
successfully casmercialized, could have a~major impact on an existing
,' 2.5 billion dollar a year U.S. industry.sG
`Gy:
As Standard of Indiana and National Distillers have already dersonstrated,
there are senior executives who can;appreciaterthat a revolution, based
~ :
~,. on biology, is beginning. Surely you must know a few individuals,
fi~
-
c
to make a formal presentation~'and',to provide them with the detailed ~^
%t r''°
,
information necessary_'io make:'an ~investment decision.
`
preferably in the oil, chem
alsor:
food industries (the areas in which
we will have our greatest-iapact)t;that you feel would be interested
at least learning more about our,, ixompany. . If so, we would be delighted ;
y
I am enclosing
two additional items for your consideration: . . .. . . ~.. . .. ..
1. Analysis of Shareholdings, which details three possible investment.
' ~ v Vt y scenarios, and;
J ~
t ~ :
{ ~gQJ
9
2, A Note.to Prospective Investor(s), which outlines our view as to
- ,_
I
why a major~corporation should consider an investment in Cetus. R~MW
~~~~,
. .. .. ,,,. ,.
:.
S;
Your help in,this matter would be very much appreciated. Needless to
say, I-Iook ~i~rward to discussing this with you in greater detail.
Cordially;o ° '
. . ..~,i. e . '
CE'P[JS CORPORATION :
geter J. Farley `
President ";
4
PJF/lmb . :
Ericlosuress
1 j
. ~ , . " . - . ~. ~" . ..
Y4
4;.
i

,
Y
Q:.P~c~~rtis.uS: :'.'S ,{ESd:p~y IQ ?s:;;!'.3.:r-_tj LrC4V 0Y:f:~ i ti.
-+iz:7.11a. 14-f swlf r -::.h.~C2" 0 i =3
iY, l.".f:i-A...J .~+K':` if .:,1,1. k t~
L7ai i1nsl'r `-`77J~. `3d1L1 Z.? C+?J'w71s?C47: : :'r'3 ~ ~. ~£ai~X J1 , Cf'~is J +*~"
!4f"t -s~ a9.~.'~
~ -
a ze,
Prxr
+1 ~ S' ikWMIy:Off -;'814
~40 ...+~..Clt
t ~ ,,,,,.~ f ,.., ,. ~. .. ;`~y
W'-,~g.'x~~ ~o`rc03~Y'~a `Ili~z:.au
:V-1 ~aa
L:x Q~.
'T.~js
& ~lu i 3a ~` .
rwo ::.:rtgO
o~lV.'
5.
't 0 t-~0
Jf~l $I_~~ril'~a1~(Y7. YC~`TC?~. 97E ~n~~
Scroa r~Ly.,r9w surroi~ i"j-
a _ o+-' am; 1 t
s-^
I-, rl,hC*0-,`~. '
~ .;[
., ;. .- .
~s4 0 pP, ii
r
.A`-
~~`
~:°1.:i~'` :'. * i" , ~? f Lot~Bxf'.-{a 'I o ~«
~ . a.. .3b ~r~+ an_N s.. ,,
, .
r ~j S~ ~~ 0 fTf~~ ~Rai
~~
c*h ,c f3:f v. 3, isr:°.Lv ~a' U i"
~O ri
'
.. " . . ', .. ~'~. G0
:f:3= DE.FG!A x9.f.J+L54 j £,ca.,f y{t.~ t~F~! f,~i3t~« Y Y£~.
if?±7t 3r l tiamL:~t'~~ L~.. '''' r~`.:yt+rx»i~~~.
O
.:i- a ... - .... . .. a' _ .. .. . . . . - . ... ., . . ~7 .~.: , .r.. .-. ..wk- ...+f4
0
0
s
©
i
. . - . , . . .. ... ..L. .. . . ,. .,,.
,
1
Ss+
.;
s
1..
